Does RISANKIZUMAB-RZAA Cause Oedema peripheral? 112 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Oedema peripheral have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
112
Reports of Oedema peripheral with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
3
Deaths
54
Hospitalizations
How Dangerous Is Oedema peripheral From RISANKIZUMAB-RZAA?
Of the 112 reports, 3 (2.7%) resulted in death, 54 (48.2%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 112 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Oedema peripheral Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA